Tandem Diabetes Care, Inc. (0M0F.L)
| Previous close | 43.25 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | 23.504M |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | 4.67 |
| EPS (TTM) | 0.09 |
| Earnings date | 20 Feb 2023 - 24 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Is There An Opportunity With Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) 49% Undervaluation?
In this article we are going to estimate the intrinsic value of Tandem Diabetes Care, Inc. ( NASDAQ:TNDM ) by...
- Business Wire
Tandem Diabetes Care Earns Great Place to Work Certification™
SAN DIEGO, November 16, 2022--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, is proud to announce its Great Place to Work Certification™, a prestigious award based entirely on results from in-depth employee surveys around their experience working at the company. This year, 84 percent of Tandem employees said it’s a great place to work – 27 points higher than the average participating company in the United States.
- Motley Fool
Buy These 2 Beaten-Growth Stocks Before They Soar
In the current market dip, growth stocks are leading the way, having lost the appeal they had during much of the 2010s. Let's look at two stocks that could soar once that happens: Tandem Diabetes Care (NASDAQ: TNDM) and Roku (NASDAQ: ROKU). Diabetes-focused medical device specialist Tandem Diabetes Care has had a terrible year, with shares plunging by 75%.
